Abstract #92059 Published in IGR 22-1

Medical Costs of and Changes in Glaucoma Treatment among Patients Newly Starting Glaucoma Care

Fukuda Y; Kume A; Kashiwagi K
Current Eye Research 2021; 0: 1-8

: To use a medical claim database to investigate medical costs and treatment patterns among patients newly starting glaucoma care.: Subjects registered in the Japan Medical Database Center (JMDC) from January 2005 to March 2016 who were newly diagnosed with glaucoma, started glaucoma treatment, and had treatment records covering more than five years were included in the analysis. All direct medical costs were collected for a period of up to ten years. Factors affecting medical costs were analyzed. Changes in hypotensive eyedrops and choices related to glaucoma surgery were also analyzed.: Out of approximately 1.42 million subjects, 2,393 satisfied the inclusion and exclusion criteria. The average total medical cost incurred per patient over a period of ten years was US$9,030, including US$1,214 during the initial year. The proportion of the total cost represented by the cost of hypotensive eyedrops increased from 5.2% to 10.6% over the ten-year period. Medical costs were higher in patients younger than ten years old than in patients of all other age groups. The number of ocular hypotensive eyedrops increased from 0.9 to 1.5 over the ten-year period. Medical costs were higher for subjects with secondary glaucoma than for other subjects. Sixty-three patients underwent trabeculotomy or trabeculectomy, and trabeculectomy was the preferred choice in later years.: The total direct medical cost associated with glaucoma was US$9,030 for the first ten years. Drug costs gradually increased with treatment duration and patient age and varied by glaucoma type.

Department of Ophthalmology, Faculty of Medicine, University of Yamanashi, Chuo, Japan.

Full article


14 Costing studies; pharmacoeconomics

Issue 22-1

Change Issue